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In situ complement activation in porcine membranoproliferative glo-
merulonephritis type II. Pigs genetically deficient in complement factor H
all develop lethal membranoproliferative glomerulonephritis (MPGN)
type II characterized by massive glomerular deposits of complement,
intramembranous dense deposits, and mesangial hypercellularity. To
elucidate the chronological relationship between these glomerular
changes, and to precisely determine the localization of glomerular com-
plement deposits, we studied kidney specimens from factor H-deficient
piglets at different ages from fetal life until terminal kidney failure had
developed. Deposits of C3 and the terminal complement complex local-
ized within the glomerular basement membrane (GBM) were present
already in factor H-deficient fetuses, without concurrent intramembra-
nous dense deposits or mesangial hypercellularity. Incipient subendothe-
lial dense deposits containing complement appeared no earlier than four
days after birth, and intramembranous dense deposits in older piglets with
established MPGN type II also contained large amounts of complement as
detected by immune electron microscopy. Onset of kidney failure coin-
cided with pronounced mesangial hypercellularity and expansion, compro-
mising glomerular capillary patency. Formation of glomerular capillary
wall double contours coincided with electron microscopic evidence of
laminar disintegration of intramembranous dense deposits. Complement
was also deposited in the mesangial matrix, but not on glomerular cells.
We conclude that all components of the alternative and terminal pathways
of complement have access into the GBM and the mesangial matrix. In the
absence of factor H, complement is spontaneously activated and deposited
in situ in these locations resulting in dense deposit formation. It is
proposed that factor H dysfunction may play an essential role even in
human MPGN type II.
The membranoproliferative (MPGN) and mesangiocapillary
(MCGN) glomerulonephritides represent kidney diseases with
obscure etiology and pathogenetic mechanisms. Based on immu-
nopathologic and ultrastructural differences, three types of
MPGN have been defined. Membranoproliferative glomerulone-
phritis types I and III have been considered to represent variants
of the same immune complex-mediated disease [1], whereas no
association with glomerular immune complexes has been ob-
served in MPGN type II. By light microscopy (LM) the latter is
characterized by capillary wall thickening, mesangial hypercellu-
larity, and lobular accentuation. The morphologic hallmark of
MPGN type II is the ultrastructural occurrence of electron dense
deposits within the glomerular basement membrane (GBM), in
the basement membranes of the Bowman’s capsules and the renal
tubular basement membranes. In spite of several attempts to
unveil the nature of the intramembranous dense deposits of
human MPGN type II, the chemical composition has remained
elusive. The intramembranous dense deposits stain with thioflavin
T and bind the lectin wheat germ agglutinin [2, 3], and the current
apprehension is that dense deposits may be composed of glyco-
proteins and lipids rich in unsaturated fatty acids, and that they
probably do not contain immunoglobulins or complement pro-
teins [4]. Human MPGN type II is associated with persistent
hypocomplementemia and alternative complement activation in
the presence of C3 nephritic factor (C3NeF) [4].
We have previously described hereditary glomerulonephritis
that is caused by an autosomal recessive factor H deficiency in pigs
of the Yorkshire breed [5–8]. The disease is characterized by
glomerular capillary wall thickening, conspicuous mesangial cell
proliferation, and the occurrence of intramembranous dense
deposits that are revealed by transmission electron microscopy
(TEM). Factor H deficient piglets have extensive systemic com-
plement activation and massive glomerular complement deposi-
tion. The disease occurs spontaneously, and it represents the only
known animal counterpart to human MPGN type II. The median
and maximum survival of 25 factor H deficient pigs were 37 days
and 72 days, respectively. In a large family study we observed an
absolute concordance between factor H deficiency and the devel-
opment of MPGN type II. All of 64 factor H deficient piglets had
hypocomplementemia with low plasma concentration of C3 and
elevated concentration of the terminal complement complex.
Furthermore, they all had glomerular deposits of C3 and the
terminal complement complex. All factor H deficient piglets that
had lived for more than one week had glomerular LM and TEM
changes diagnostic for MPGN type II, and eventually died of renal
failure [8]. In contrast, heterozygous animals were healthy and
indistinguishable from homozygous factor H sufficient animals,
except they exhibited a half normal plasma concentration of factor
H [9].
To describe the chronological relationship between glomerular
complement deposition and formation of intramembranous dense
deposits in porcine MPGN type II, we performed light microscopy
(LM), immunofluorescence microscopy (IFM), and transmission
electron microscopy (TEM) on renal tissues obtained by autopsy
Key words: porcine MPGN, membranoproliferative glomerulonephritis,
complement activation, factor H dysfunction.
Received for publication May 30, 1997
and in revised form September 11, 1997
Accepted for publication September 17, 1997
© 1998 by the International Society of Nephrology
Kidney International, Vol. 53 (1998), pp. 331–349
331
or by percutaneous renal biopsies from factor H deficient piglets
at various ages. In addition, immune electron microscopy (IEM)
was used to examine the subcellular localization of complement
deposits within the glomerular capillary wall, and their relation to
intramembranous dense deposits. The course of the disease was
also recorded by complementologic, biochemical and hematolog-
ical analyses.
METHODS
Animals
Parent animals heterozygous deficient in factor H were mated
for the production of the experimental animals used in the present
study. Nine homozygous factor H deficient piglets and five normal
littermates were subjected to renal biopsies. Since animals het-
erozygous for factor H deficiency generally are healthy, these
piglets were classified as normals together with the homozygous
factor H sufficient animals. Kidneys from six stillborn piglets with
unknown factor H status were also examined. Three of these had
massive glomerular complement deposits diagnostic for factor H
deficiency, whereas the remaining were normal [8]. One homozy-
gous factor H deficient sow was partially factor H substituted by
regular plasma transfusion and, thus, remained alive for 375 days
[7]. It had been mated with a heterozygous factor H deficient
boar, and when it died 80 days later it had 10 fetuses in utero (35
days preterm) [8]. Another heterozygous factor H deficient sow
that was mated with a heterozygous boar was sacrificed because of
disabling lameness 80 days later, and had nine fetuses in utero.
The quantitation of factor H in plasma from the fetuses revealed
that 10 were factor H deficient and nine were normal. The kidneys
of all the fetuses were examined. Altogether, the present study
comprised an examination of kidney samples collected from 22
factor H deficient and 17 normal piglets.
From the 14 piglets born alive (9 factor H deficient and 5
normal), a total of 46 renal biopsies were obtained at different
ages: on day one (N 5 1 factor H deficient 1 4 normal), day four
(N 5 5 1 1), day 14 (N 5 9 1 1), day 21 (N 5 9 1 1), day 28 (N 5
7 1 1), day 35 (N 5 3 1 1), day 42 (N 5 2 1 0), and day 49 (N 5
1 1 0). The nine biopsied factor H deficient piglets eventually
died of renal failure or were sacrificed because of severe clinical
signs of uremia, except from one that was euthanized because of
clinical impairment caused by a biopsy-induced fibrinopurulent
peritonitis. Kidney specimens from these animals were collected
at autopsy, and from four of these animals and three normal
piglets, richly vascularized extrarenal tissues were collected as
well: spleen, lung, synovial membranes, the ciliary body of the eye,
and the choroid plexus of the lateral ventricles of the brain. These
tissues were examined by LM and IFM as described below for
kidney specimens with the purpose of revealing any extrarenal
lesions.
Renal tissue from 12 factor H deficient or normal piglets was
examined by IEM. These were fetuses on the 80th day of gestation
(N 5 2 factor H deficient 1 2 normal), newborn piglets (N 5 3
factor H deficient), two weeks old (N 5 2 factor H deficient), and
four weeks old (N 5 2 factor H deficient and 1 normal). All
liveborn piglets were sacrificed by intraperitoneal or intravenous
overdosage of pentobarbital.
All liveborn piglets were routinely treated with one subcutane-
ous injection of 2 ml colloidal ferridextran complex (Idofer vet.;
Boehringer Ingelheim Agrovet A/S, Hellerup, Denmark) on their
third day of life to prevent neonatal iron deficiency anemia.
Piglets biopsied on the day of birth were treated with ferridextran
that day.
Biopsy procedures
The piglets were put in left lateral recumbency under total
surgical anesthesia induced by intravenous injection of 0.25 ml/kg
body wt of alfaxalonum 9 mg/alfadolon-aceticum 3 mg per ml
(SAFFANy ad us. vet.; Pitman-Moore GmbH, Bern, Switzer-
land). The kidneys were identified by transabdominal digital
palpation, and by ultrasonography. Biopsies were obtained per-
cutaneously from the right kidney using the Bard® Biopty-Cut®
device (C.R. Bard Inc., Covington, GA, USA) with 18G/1.2 mm
biopsy needles. All biopsies were divided in three parts for LM,
TEM, and indirect IFM.
Light microscopy
Kidneys obtained by autopsy were perfused with Ringer’s
acetate via the renal artery until clear effluent. Fetal kidneys were
not perfused because of the small sized arteries. Coronal cut slices
from these kidneys and the biopsies were fixed by immersion in
phosphate buffered 4% formaldehyde, dehydrated in graded
ethanols, and embedded in paraffin. Four-micrometer thick sec-
tions were stained with hematoxylin-eosin (HE), periodic acid-
Schiff (PAS), Masson’s trichrome stain, and Perls’ Prussian blue
method for hemosiderin (ferric iron). Furthermore, semithin (1
mm thick) epon embedded parts of all biopsies processed for
TEM were stained with toluidine blue and examined under the
light microscope.
Immunofluorescence microscopy
Renal biopsies were embedded in TISSUE-TEK® O.C.T. com-
pound (Miles Inc., Elkhart, IN, USA). Embedded biopsies and
the coronal cut slices from Ringer perfused kidneys were flash
frozen in chlorodifluoromethane (Isceony; ISC Chemicals Ltd.,
Bristol, UK) cooled in liquid nitrogen. Indirect immunostaining
for C3 and the terminal complement complex was performed as
previously described [6], using rabbit antiserum against porcine
C3 (Organon Teknika BCA/Cappel, West Chester, PA, USA) and
a cross reacting monoclonal antibody against a C9 neoepitope in
the human terminal complement complex (clone aE11) as pri-
mary antibodies [10]. Fluorochrome-labeled secondary antibodies
used were goat-anti-rabbit-IgG-fluorescein isothiocyanate (FITC)
and goat-anti-mouse-IgG-tetramethyl rhodamine isothiocyanate
(TRITC), both purchased from Sigma Chemical Co. (St. Louis,
MO, USA). Direct staining of frozen renal sections was per-
formed with FITC-labeled wheat germ agglutinin (Triticum vul-
garis) from Sigma diluted to 20 mg/liter in a 3% solution of bovine
serum albumin in phosphate buffered saline.
Transmission electron microscopy
About 0.5 mm thick tissue slices from fetal kidneys and the
renal biopsies were fixed by immersion in 0.1 M phosphate buffer,
pH 7.4, containing 3% glutaraldehyde. Other kidneys obtained at
autopsy were perfused with Ringer’s acetate prior to fixation by
perfusion with a glutaraldehyde buffer. All specimens were post-
fixed in 2% osmium tetroxide in 0.1 M cacodylate buffer, dehy-
drated in ethanol, and embedded in epon LX112 (Ladd Research
Industries Inc., Burlington, VT, USA). Semithin (1 mm thick)
sections were stained with toluidine blue and examined by LM for
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selection of glomeruli. In fetal and neonatal kidneys, only the
deep cortical mature, blood-perfused glomeruli were selected for
TEM. Ultrathin sections were stained with uranyl acetate and lead
citrate, and examined in a Jeol 100S electron microscope. Gen-
erally three glomeruli were examined from each renal specimen.
In some biopsy specimens only one glomerulus was present, and
one biopsy contained no glomeruli. The severity of lesions ob-
served by LM, IFM, and TEM were graded on a scale of 0 to 31
[11] (Table 1).
Immune electron microscopy
The left kidneys were removed immediately after onset of
surgical anesthesia, and were perfused via the renal artery with
Ringer’s acetate prior to perfusion fixation with a 0.3 M phosphate
buffer, pH 7.4, containing 2% paraformaldehyde and 0.05%
glutaraldehyde. After fixation, the cortex was cut in cubes approx-
imately 0.5 mm3, and subsequently immersed in the same fixative
for 60 minutes. Dehydration was performed in graded ethanol
with progressive lowering of temperature [12, 13]; 30 minutes in
30% ethanol at 0°C, 60% ethanol at 215°C, 70% ethanol at
220°C; 60 minutes in 90% ethanol at 220°C; 120 minutes in
absolute ethanol at 220°C. Immersion in resin (Unicryl; British
Biocell, Cardiff, UK) at 220°C was performed overnight, and
polymerization of blocks was accomplished by UV illumination at
220°C for four days, and finally by UV illumination for one day at
14°C. Semithin sections (1 mm thick) were stained with toluidine
blue and examined under the light microscope for selection of
glomeruli. Immunolabeling was performed according to the
method described by Robertson and co-workers [13]. The primary
antibodies were polyclonal antibodies to porcine C3 (Organon
Teknika BCA/Cappel), diluted 1:6000, or rabbit antiserum to the
porcine terminal complement complex diluted 1:4000. The latter
antiserum was produced in our own laboratory by immunizing
rabbits with purified porcine soluble terminal complement com-
plex (SC5b-9) that was purified from zymosan-activated citrated
plasma essentially as described [14], using a Sepharose-linked
monoclonal antibody (aE11) to a C9 neoepitope expressed on
SC5b-9, followed by MonoQ HPLC ion-exchange chromatogra-
phy.
The primary antibodies were detected by anti-rabbit IgG con-
jugated to 5-nm gold particles (Amersham, Buckinghamshire,
UK) diluted 1:50. Silver enhancement was obtained using a silver
enhancing kit (Amersham) for six minutes. After washing, the
sections were contrasted by standard procedures with uranyl
acetate and lead citrate. All sections were also incubated directly
with the secondary antibody, without previous exposure to the
primary antibodies.
Blood analyses
Blood was sampled from 107 piglets (34 factor H deficient and
73 normal) at different ages, and 426 samples were taken alto-
gether. Each sample was collected by jugular venopuncture into
EDTA-containing tubes or tubes without additive. Factor H, C3,
and the terminal complement complex were measured in EDTA
plasma by enzyme immunoassays as described [6, 7] in all animals
except from stillborns. Total protein, albumin, urea, creatinine,
inorganic phosphate, calcium, cholesterol, and triglycerides were
determined in serum by standard procedures on the Technicon
Axon® analyzer (Bayer Corp., Tarrytown, NY, USA). Globulin
fractions were determined by serum protein electrophoresis by
standard procedures using the Beckman Paragon® system and the
Beckman Appraise® Densitometer (Beckman Instruments Inc.,
Brea, CA, USA). Hematological examination including hemoglo-
bin concentration, hematocrite, red blood cell count, total white
blood cell count, and differential white blood cell count including
neutrophils, lymphocytes, platelets and mean platelet volume
were performed on blood samples collected in EDTA-containing
tubes using the Technicon Hz1Ey multi-species hematology sys-
tem from the Bayer Corp., implementing a modification of the rat
application.
Table 1. Renal immunofluorescence-, light-, transmission electron- and immune electron microscopy lesions (autopsy material and biopsies) from
factor H deficient piglets
Fetal, stillborn
or day 1 4 days 2 weeks 3 weeks 4 weeks
5 and
6 weeks
Immunofluorescence microscopy
Glomerular capillary wall complement deposits 21 31 31 31 31 31
Mesangial complement deposits 0 11 21 31 31 31
Capillary wall double contours 0 0 0 0 0 31
Light microscopy
Mesangial hypercellularity 0 11 21 31 31 31
Glomerular neutrophil accumulation 0 11 21 31 31 31
Glomerular capillary occlusion 0 0 0 21 31 31
Capillary wall double contours 0 0 0 0 0 31
Crescentic lesions 0 0 0 0 11 31
Tubular degeneration and atrophy 0 0 11 21 31 31
Interstitial fibrosis 0 0 11 21 31 31
Transmission electron microscopy
Intramembranous dense deposits in the GBM 0 11 21 31 31 31
Mesangial dense deposits 0 11 21 31 31 31
Laminar intramembranous GBM lucencies 0 0 0 0 11 31
Immune electron microscopy
Complement deposits within the GBM 31 n.e. 31 n.e. 31 n.e.
Complement within dense deposits — n.e. 31 n.e. 31 n.e.
The abbreviations are: GBM, glomerular basement membrane; n.e., not examined.
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Body weights
The nine biopsied factor H deficient piglets were weighed
repeatedly until they died. The weight curves for these piglets
were compared with the normal weight curves calculated from
1312 observations in 273 normal Yorkshire piglets, most of them
being littermates of factor H deficient piglets. Weight data from
102 additional factor H deficient piglets were also analyzed.
Ethics
This study was carried out at a Laboratory Animal Unit
approved by the National Animal Research Authority for such
work on pigs. The protocol was approved by the Unit’s Competent
Person, according to the Regulations (1996) under the Norwegian
Animal Welfare Act of 1974.
Statistics
The Mann-Whitney two sample test was used. In the present
study 75 statistical comparisons were made, and consequently the
Bonferoni correction should be employed. Thus, P , 0.0007 was
considered significant, although most P values in the area 0.05 to
0.0007 will reflect real trends.
RESULTS
The renal biopsy procedure was well tolerated by most piglets.
Macroscopic hematuria of short duration without any other
clinical signs was frequently observed. However, all of four normal
piglets that were biopsied on their first day of life died or had to
be euthanized within the first few days because of impaired
suckling and lethargy as signs of severe clinical impairment. The
initial biopsy was therefore postponed in other pigs, although
autopsy of these piglets revealed no biopsy-induced renal trauma
as the causes of clinical impairment. One factor H deficient piglet
that was biopsied on the day of birth developed normally, and
renal biopsies from this piglet was also obtained at two and three
weeks of age. This piglet was euthanized 24 days old after the
third biopsy because of clinical signs of a biopsy-induced fibrino-
purulent peritonitis. The main immunopathologic and morpho-
logic results are summarized in Table 1. Some clinical parameters
of individual piglets at the time of renal biopsy or autopsy are
presented in Table 2.
Immunofluorescence microscopy
No complement deposits were observed in any glomerulus from
normal fetuses or normal stillborn piglets, and linear complement
deposits was never observed in any normal piglet. Granular
mesangial and paramesangial positive staining for C3 was fre-
quently observed in the normal piglets, increasing with age.
Scattered weakly positive staining for the terminal complement
complex could occasionally be seen in association with these
mesangial and paramesangial C3 depositions in two-week-old and
older normal piglets.
In factor H deficient piglets massive glomerular complement
deposits were present at any age. The pattern was as follows: In
the fetuses, the mature deep juxtamedullary blood perfused
glomeruli revealed delicate smooth linear deposition of both C3
and the terminal complement complex along the capillary walls.
Some short segments of the capillary loops showed predominant
C3 deposition, whereas in most segments the staining for C3 and
the terminal complement complex was of comparable intensity
(Fig. 1A). There was no mesangial complement deposition. The
immature, non-perfused glomerular anlage of the outer cortex
revealed no complement deposition, whereas maturing stage
glomeruli in the midcortical zone revealed short interrupted
segments of deposits along the capillary walls, most often domi-
nated by C3. Similar positive linear pattern for C3 and the
terminal complement complex was observed in the stillborn and
newborn piglets.
At four days there was a more coarse linear staining for C3 and
the terminal complement complex along the capillary walls. In
addition there was some mesangial staining for C3 (Fig. 1B).
At two weeks and later there was increasingly coarse linear
immunofluorescence (IF) both for C3 and the terminal comple-
ment complex along the capillary walls without the presence of
double contours. Mesangial C3 deposition was more prominent
than mesangial terminal complement complex deposition at two
weeks. With increasing age the mesangial complement deposits
became more abundant and more granular, with similar staining
patterns for C3 and the terminal complement complex. The
increasing mesangial hypercellularity was reflected in the copious
IF-negative images of mesangial nuclei outlined by the mesangial
complement deposits.
Coarse IF for C3 and the terminal complement complex along
the capillary walls and massive granular mesangial complement
deposits were also observed at five weeks and later. At this stage,
an increasing occurrence of circumferential double contoured
capillary loops were observed (Fig. 1C).
Direct IF using FITC-labeled wheat germ agglutinin revealed
binding to resident glomerular cells and the capillary walls in
normal piglets. Binding of wheat germ agglutinin along the
glomerular capillary walls was conspicuously enhanced in the
two-week-old and older factor H deficient piglets (Fig. 1D).
Light microscopy
Kidney specimens from fetuses and stillborns revealed no
glomerular changes in the factor H deficient individuals (Fig. 2A).
No light microscopic changes were evident in the kidney biopsy
Table 2. Some clinical parameters of piglets at the time of renal biopsy or autopsy
Figure
Age
days
Weight
kg
Clinical
condition
Albumin
g/liter
Urea
mM
Creatinine
mM
Hgb
g/liter
WBC Neutrophils
109/liter
1A, 2A, 4 (a) fetus n.r. — n.r. n.r. n.r. n.r. n.r. n.r.
1B, 2B, 3B (b) 4 1.9 unaffected n.r. n.r. n.r. n.r. n.r. n.r.
2C (b) 14 4.8 unaffected 28.4 2.7 66 111 7.01 3.97
2D (b) 21 6.4 unaffected 21.6 7.4 139 95 8.77 5.33
2E (b) 28 8.3 lethargic 16.0 19.4 202 90 14.59 8.24
1C, 2F, 3C (a) 35 8.6 dead 14.7 120 1898 n.r. n.r. n.r.
Abbreviations are: n.r., not recorded; Hgb, hemoglobin; WBC, white blood cells; (a), autopsy; (b) biopsy.
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from one factor H deficient piglet on the day of birth. Hence, it
was not possible to distinguish between factor H deficient and
normal piglets by LM before or at birth.
The earliest appearance of morphologic glomerular lesions in
factor H deficient piglets was at four days of age when incipient
mesangial hypercellularity and mesangial expansion were ob-
served (Fig. 2B). Polymorphonucleocytes were more frequently
observed in the glomerular capillaries of the four-day-old factor H
deficient piglets than in normal piglets. Mesangial golden-brown-
ish granules that stained deep blue with the Perls’ Prussian blue
method were identified as mesangial hemosiderin that is formed
subsequent to ferridextran treatment. These mesangial hemosid-
erin deposits were larger and more numerous in the glomeruli of
factor H deficient piglets than in the normal piglets. Renal tubuli
and interstitium in factor H deficient piglets were normal at this
age.
Mesangial hypercellularity was more pronounced in the two-
week-old factor H deficient piglets, and large amounts of mesan-
gial hemosiderin was observed (Fig. 2C). The capillary walls
appeared slightly thickened with the PAS stain, and numerous
neutrophils were observed within the open glomerular capillaries.
Scattered proximal tubular cells contained hyaline, PAS-positive
protein droplets and occasional distal tubules and collecting ducts
contained hyaline, PAS-positive proteinacous casts. Clinical data
are shown in Table 2.
By three weeks of age, the mesangial hypercellularity was
striking. The expanding mesangium occupied most of the glomer-
ular tufts, displacing the glomerular capillaries to the periphery,
and diminishing the patency of glomerular capillary lumens (Fig.
2D). Neutrophils were present in almost every glomerular capil-
lary loop, and the capillary walls were conspicuously thickened.
Proximal tubular hyaline droplet degeneration was prominent and
areas of proximal tubular atrophy could be observed along with
interstitial fibrosis.
At four weeks, the expanded and hypercellular glomerular
mesangium occupied most of the transected glomerular areas with
partially collapsed or occluded capillaries interposed between the
expanding mesangium and the thickened capillary walls at the
Fig. 1. Indirect (except from D) immunofluorescence microscopy performed on frozen kidney specimens (autopsies and biopsies) from factor H
deficient piglets. Double labeling with polyclonal antibodies against swine C3 (FITC) and a cross reacting monoclonal antibody against the human
terminal complement complex (TRITC stain; magnification 3350). (A) A large juxtamedullary glomerulus from a fetal kidney (35 days preterm)
showing a delicate smooth linear pattern of C3 and terminal complement complex deposition confined to the glomerular capillary walls. (B) Biopsy
specimen from a four-day-old piglet showing coarse linear deposition of C3 and the terminal complement complex along the glomerular capillary walls.
There is some mesangial staining for C3. (C) Autopsy specimen from a five-week-old piglet showing coarse linear depostion of C3 and the terminal
complement complex along the capillary walls and granular mesangial deposits. Double contoured capillary walls are readily visible. The exudate into
Bowman’s capsule also shows staining for complement. (D) Autopsy specimen from a four-week-old piglet. Direct immunofluorescence microscopy with
fluorescein-conjugated wheat germ agglutinin showing enhanced binding along the glomerular capillary walls.
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periphery of the glomerular tufts (Fig. 2E). Beginning crescentic
lesions were occasionally observed. Proximal tubular atrophy was
frequently seen together with interstitial fibrosis. Several distal
tubules contained proteinacous PAS-positive casts and neutrophil
cellular casts.
At five weeks and later, several capillary walls revealed double
contours that often appeared as circumferential lesions along the
walls of the capillary loops (Fig. 2F). Fibrinous exudation to the
Bowman’s space was frequently observed along with beginning
crescentic lesions, and extraglomerular lesions comprising proxi-
mal tubular atrophy and interstitial fibrosis were pronounced.
The glomerular size and lobulation was remarkably increased in
factor H deficient piglets from two-weeks of age when compared
with age-matched normal piglets.
Transmission electron microscopy
The ultrastructural examination of fetal kidneys revealed no
differences between factor H deficient and normal fetuses, and
neither were there any differences in stillborns or newborns (Fig.
3A). Occasional short segments of the glomerular capillary walls
in these piglets revealed separation of the endothelial cells from
the GBM concurrent with widening of the lamina rara interna,
and occasional short split segments of the GBM with lamellation
of the lamina densa could be observed. However, these changes
were observed as equally frequent in glomeruli from factor H
deficient and normal piglets.
The earliest appearance of electron dense deposits was seen at
four days. The dense dense deposits initially appeared within the
subendothelial side of the lamina densa, and the GBM appeared
slightly thickened with numerous small irregularities along the
subepithelial side. Incipient effacement of the visceral epithelial
foot processes could also be observed in these piglets (Fig. 3B).
At two weeks, the dense deposits along the subendothelial side
of the GBM, the GBM thickening and the subepithelial GBM
irregularities were more pronounced, as well as the visceral
epithelial cell foot process effacement. A beginning visceral
A
B
Fig. 2. Light microscopic (LM) findings in
factor H deficient piglets. Semithin sections are
stained with toluidine blue (3455). (A)
Juxtamedullary glomeruli from a fetal kidney
(35 days preterm). No glomerular LM changes
are evident (autopsy specimen). (B) Biopsy
specimen showing “fetal” glomeruli from a
four-day-old piglet. Slight mesangial
proliferation (3424). (C) Biopsy specimen from
a 2-week-old piglet showing pronounced
mesangial hypercellularity. Numerous
neutrophils are seen in the open glomerular
capillaries. (D) Biopsy specimen from a three-
week-old piglet. The capillary lumens are partly
occluded and displaced to the periphery of the
expanded and hypercellular mesangium. (E)
Biopsy specimen from a four-week-old piglet
showing conspicuous mesangial hypercellularity
and mesangial expansion leading to occlusion of
the glomerular capillary lumens. (F) Autopsy
specimen from a five-week-old piglet showing
fibrinous exudation to the Bowman’s space.
Numerous capillary walls with double contours
are readily visible.
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epithelial cell microvillus formation was also observed. The
endothelial cells appeared swollen, and there was an augmenta-
tion of cytoplasmic organelles, especially the rough endoplasmatic
reticulum, in all resident glomerular cells (the visceral epithelial
cells, the mesangial cells and the endothelial cells). These changes
were more pronounced with increasing age. At three weeks, the
dense deposits occupied more of the GBM, and the coarse
subepithelial irregularities of the GBM sometimes contained
dense deposits as well. Incipient disintegration of the intramem-
branous dense deposits was observed at four weeks, creating
lucencies within, and occasional interruptions of the GBM with
gap formation. Fibrinous exudation to the Bowman’s space was
associated with the occurrence of such GBM interruptions. At five
weeks and later, such disintegration of the dense deposits were
widespread, and often occurred as circumferential intramembra-
nous lucencies along the entire wall of the capillary loops, creating
the image of double contours in the capillary walls (Fig. 3C).
Increasing amounts of mesangial dense deposits similar to in-
tramembranous dense deposits was observed increasing with age.
Large amounts of hemosiderin was observed in mesangial cell
phagosomes already at four days. As observed by LM these
deposits were more abundant and larger in the factor H deficient
piglets than in normal piglets, and they persisted throughout the
study period. Mesangial cytoplasmatic interposition was fre-
quently observed between the GBM and the capillary endothe-
lium in the expanded paramesangial regions adjacent to the
glomerular capillaries. The interposition was usually partial and
only rarely circumferential, and it was not associated with reduplica-
tion of the GBM. Neither the basement membrane of the Bowman’s
capsule nor the tubular basement membranes contained dense
deposits. The glomerular capillaries of factor H deficient piglets
contained conspicuously numerous neutrophils already at four
C
D
Fig. 2. Continued.
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days and this neutrophil cell accumulation increased with age.
There was no glomerular capillary platelet accumulation in any of
the factor H deficient piglets at any age.
Immune electron microscopy
In factor H deficient fetuses and newborn piglets complement
C3 (Fig. 4A) and the terminal complement complex (Fig. 4B)
were detected within the the GBM in a similar diffuse pattern. At
two weeks stronger staining for complement C3 (Fig. 5A) and the
terminal complement complex (Fig. 5B) was also observed in the
intramembranous dense deposits arising from the subendothelial
side of the GBM.
At four weeks the GBM was thickened due to massive amounts
of intramembranous dense deposits (Fig. 6A), that showed strong
staining for C3 (Fig. 6B) and the terminal complement complex
(Fig. 6C). No complement was deposited within the GBM in the
normal control piglets (Fig. 6D). Control stainings were consis-
tently negative. Laminar disintegration of the intramembranous
dense deposits was frequently observed at four weeks, creating
double contours of dense deposits staining for complement (Fig.
7). At this age complement was deposited in the mesangial matrix
both diffusely and within discrete mesangial dense deposits of
similar density as the intramembranous dense deposits. Comple-
ment was never deposited on endothelial, epithelial, or mesangial
cell surfaces.
Examination of extrarenal tissues
No pathologic changes could be observed by LM examination
in any of the extrarenal tissues examined. Immunofluorescence
E
F
Fig. 2. Continued.
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microscopy for detection of complement deposits in these tissues
was consistently negative.
Blood analyses
The results of blood analyses in factor H deficient and normal
piglets at two, four and six weeks are summarized in Table 3.
Weight development
The biopsied factor H deficient piglets had a normal weight
gain from birth until three to five weeks age when growth
retardation occurred (Fig. 8). Growth retardation was closely
associated with severe renal failure, with increasing serum con-
centration of urea and creatinine. Weight data from 102 factor H
deficient and 269 normal piglets were compared. The median
weight of factor H deficient piglets was slightly higher than for
normal pigs from birth until three weeks age, but at four to six
weeks age it was lower. These observed weight differences were,
however, not statistically significant at any age.
DISCUSSION
The present study clearly demonstrate that the glomerular
capillary wall complement deposits in factor H deficient pigs are
localized within the GBM and in the mesangial matrix, and not on
resident glomerular cells. Factor H deficient fetuses had normal
glomerular morphology and no intramembranous dense deposits,
but were hypocomplementemic and possessed deposits of C3 and
the terminal complement complex within the GBM. Conse-
quently, this study presents unequivocal evidence of complement
activation within the GBM that precedes any morphologic sign of
glomerulonephritis. Furthermore, we present direct evidence that
the intramembranous dense deposits of porcine MPGN type II,
A
B
Fig. 3. Transmission electron micrographs
from factor H deficient piglets at increasing
ages. Abbreviations are: cl, capillary lumen;
GBM, glomerular basement membrane; PMN,
polymorphonucleated leukocyte (neutrophil);
us, urinary space (magnification: A and B,
316,500; C, 36,560). (A) Stillborn piglet at
term. Glomerular capillary wall with no dense
deposits in the GBM. (B) At four days, a thin
but distinct band of dense deposits appears
within the subendothelial aspect of the lamina
densa. The GBM appears slightly thickened.
(C) At five weeks the circumferential laminar
disintegration of the intramembranous dense
deposits creates intramembranous lucencies
with double contours.
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when these eventually are formed, contain large amounts of
complement.
The incipient complement deposition observed in the fetal
maturing stage glomeruli indicates that the process of comple-
ment deposition within the GBM starts with the commencement
of blood perfusion of the glomerular anlage. This observation
suggests that fetal glomerular complement deposition is not a
result of local production of complement components, but rather
a result of the exposure of the glomerular capillary walls to
circulating blood in factor H deficient fetuses. The almost iden-
tical C3 and terminal complement complex glomerular co-depo-
sition further suggests that in situ glomerular complement activa-
tion is a more probable pathogenetic mechanism than glomerular
trapping of circulating complement activation products, since
passive trapping of preformed activated C3 and terminal comple-
ment complex hardly would have resulted in a smooth and even
deposition. Furthermore, in the factor H deficient fetuses, capil-
lary wall terminal complement complex deposits were present in
spite of the fact that the plasma concentration of the soluble
terminal complement complex was lower than in normal piglets
after birth (Table 4), and normal piglets never have such terminal
complement complex deposits [8]. Examination of the comple-
ment deposits is consistent with C3 deposition within the GBM
and in the mesangial matrix that chronologically precedes termi-
nal complement complex deposition, the latter in its soluble form,
SC5b-9, since it contains vitronectin [6]. The presence of comple-
ment deposits in factor H deficient fetuses virtually exclude any
role of immune complexes in this disease, since the concentration
of immunoglobulins in porcine fetal blood is insignificant (, 50
mg/liter) [15]. It is remarkable that such vivid complement
deposits can be formed in fetal life of piglets, as the complement
system apparently is still immature with a physiological hypo-
complementemia, revealed as low C3 in the normal fetuses (Table
4). As far as we know, this is the first report on complement
deposition in utero.
The observed deposition of complement within the GBM
implies that all the complement proteins required for alternative
pathway and terminal pathway complement activation are readily
available within the GBM, apparently due to low grade filtration.
These components are C3, factor B, factor D, C5, C6, C7, C8, and
C9, of which C5 is the largest with a molecular weight of 190 kDa.
Obviously factor H is strictly required to restrict spontaneous
complement activation within the GBM, at least in pigs. When the
GBM is exposed to complement in the absence of factor H, the
GBM will function as a nidus for complement activation. Unlike
the resident glomerular cells surrounding the GBM, the GBM
itself is not protected by membrane-bound complement inhibi-
tors, such as decay accelerating factor (DAF), membrane cofactor
protein (MCP), and complement receptor 1 (CR1). It is probable
that the continuous complement attack on the GBM with increas-
ing deposition of complement proteins into the membrane results
in a gradual increase in the electron density of the GBM.
According to the observations by IEM this process apparently
starts from the subendothelial side of the GBM, this side being
exposed to the factor H deficient plasma through the endothelial
fenestra of the glomerular capillaries. Similarly, the mesangial
matrix is also readily exposed to plasma and lacks complement
inhibitors. This may explain the similar pattern of mesangial
complement activation compared with the GBM. In addition,
some of the discrete mesangial dense deposits staining for com-
plement at four weeks may represent mesangial uptake of disin-
tegrating intramembranous dense deposits. Our data do not,
however, exclude the possibility that abnormally organized normal
GBM constituents may contribute to the increased electron
density.
The observation by IEM that intramembranous dense deposits
indeed contain large amounts of complement, support the view
that the GBM double contours in factor H deficient piglets are
caused by laminar disintegration and dissolution of the intramem-
branous dense deposits with generation of circumferential in-
tramembranous lucencies. This disintegration is possibly caused
by the deposition of large amounts of complement within the
GBM, disrupting the integrity of this structure. The presence of
C
Fig. 3. Continued.
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AB
Fig. 4. Immune electron microscopy (IEM) of the glomerulus from a factor H deficient porcine fetus on the 80th day of gestation (35 days preterm).
The tissues were stained with rabbit antisera against C3 or the terminal complement complex, followed by secondary antibodies conjugated with 5 nm
gold particles, and finally silver enhanced. Positive staining for complement within the lamina densa for (A) C3 and (B) the terminal complement
complex. Abbreviations are: CL, glomerular capillary lumen; EC, endothelial cell; GBM, glomerular basement membrane; VEC, visceral epithelial cell
(podocyte).
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AB
Fig. 5. Two weeks age. Immune electron
microscopy (IEM) reveals accentuation of
immune staining for complement (A) C3 and
(B) the terminal complement complex within
the incipient intramembranous dense deposits
on the subendothelial side of the GBM.
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Fig. 6. Four weeks age. Electron micrographs of a factor H deficient piglet (A-C) and a normal control piglet (D). (A) Transmission electron microscopy
(TEM) revealing a conspicuously thickened GBM with massive intramembranous dense deposits. By immune electron microscopy (IEM) the intramembra-
nous dense deposits contain large amounts of (B) C3 and (C) the terminal complement complex. (D) IEM of the normal GBM without staining for C3.
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membrane bound inhibitors of the adjacent cells (visceral epithe-
lial cells and endothelial cells) on either sides of the GBM may
inhibit this structural disruption to such an extent that disintegra-
tion is reduced and continuity is preserved at the periphery of the
GBM.
Factor H deficient piglets had normal weight gain and were
clinically totally inconspicuous during the first weeks of life,
showing that the extensive systemic and local complement activa-
tion and the severe glomerulonephritis had little impact on their
development and well-being. A relatively abrupt onset of
azotemia, weight retardation and failure to thrive were clinical
signs that commonly appeared first at three weeks of age in factor
H deficient piglets. This coincided with the morphologic observa-
tion in renal biopsies of pronounced mesangial hypercellularity
and mesangial expansion, leading to diminished patency and a
gradual obliteration of the glomerular capillary lumens. These
observations indicate that obstruction of glomerular blood flow
caused by the expanding mesangium may be the main mechanism
leading to renal failure in these piglets.
The mesangial deposition of hemosiderin observed both in the
factor H deficient and normal piglets was interpreted as mesangial
storage of iron subsequent to the neonatal subcutaneous injection
of ferridextran. The increased hemosiderin deposition in the
hypercellular mesangium of the factor H deficient glomerulone-
phritic piglets is concordant with observations in the complement-
mediated experimental rat anti-Thy-1.1 model of mesangial pro-
liferative glomerulonephritis [16] in which there is an increased
macromolecular uptake by the hypercellular mesangium [17].
The serum concentration of g-globulins in two- to four-week-
old factor H deficient piglets was significantly and substantially
lower than in normal piglets, whereas this difference largely
disappeared in the five- and six-week-old piglets. The reason for
this reduced level of g-globulins in the factor H deficient piglets is
enigmatic. The bulk of g-globulins is represented by IgG, which in
piglets are absorbed from colostrum mainly during the first day of
life [18]. The normal neonatal weight gain of factor H deficient
piglets indicates normal suckling. Low levels of factor H and
other complement components can hardly quantitatively con-
tribute to the observed difference, since only C8 of the relevant
components migrates in the g-region. Porcine factor H mi-
grates in the b2-region [7], and most other complement
components are b-globulins (at least the corresponding human
components) [19].
From four weeks age the factor H deficient piglets had a
relative leukocytosis. The white blood cells were dominated by
circulating neutrophils in factor H deficient piglets at all ages, in
contrast to normal pigs where circulating white blood cells are
dominated by lymphocytes. It is possible that this observed
neutrophilia was caused by the continuous activation of comple-
ment, since C5a is known to release neutrophils from the bone
marrow [20]. C5a might also be partly responsible for the glomer-
ular accumulation of neutrophils. In addition, the persisting
Fig. 7. Four weeks age. Laminar disintegration of the intramembranous dense deposits form double contours that are stained for C3.
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generation of C5a and the terminal complement complex along
the GBM may induce expression of adhesion molecules on
glomerular endothelial cells as well as secretion of neutrophil
activators and chemotaxins [21]. The observations of increasing
numbers of circulating neutrophils and striking glomerular neu-
trophil localization indicate a pathogenetic role of neutrophils in
the development of porcine MPGN type II.
A causal connection was anticipated to exist between the
unrestricted systemic complement activation with C3 consump-
tion and increased terminal complement complex formation, and
the massive local glomerular deposits of C3 and the terminal
complement complex in factor H deficient piglets [6, 7]. It was,
however, not quite clear if the glomerular complement deposits
were formed by in situ glomerular complement activation or if
they were produced by glomerular trapping of circulating acti-
vated complement components. The present results provide firm
evidence that in situ complement activation is the primary insult
that eventually causes development of glomerular nephritis mor-
phologically characterized by intramembranous dense deposits,
mesangial cell proliferation and glomerular neutrophil localiza-
tion. In a recent series of renal allotransplantation experiments
between factor H sufficient and factor H deficient pigs, two factor
H deficient pigs were functionally nephrectomized for two days
without normalization of the hypocomplementemia [22]. This
observation provide further evidence that porcine factor H defi-
ciency causes both systemic and local complement activation, but
that these two processes are mutually independent. The systemic
complement activation with hypocomplementemia may, in fact,
have some restraining impact on the local complement activation
by limiting the supply of native complement components for in
situ glomerular complement activation. The hypocomple-
mentemia did not seem to cause any specific organ dysfunction in
pigs, and no increased susceptibility to infectious diseases was
observed that could be expected in a state of aquired hypocomple-
mentemia [23]. On the other hand, local glomerular complement
activation that occurs within the GBM and the mesangial matrix
is the primary pathogenetic event of porcine MPGN type II that
eventually leads to kidney failure and uremic death.
Porcine membranoproliferative glomerulonephritis type II as a
model of human glomerulonephritis
Porcine MPGN type II in factor H deficiency has several
features that closely resemble the human counterpart. The TEM
demonstration of intramembranous dense deposits within the
GBM is a prerequisite of the diagnosis. In both the human and the
porcine diseases the intramembranous dense deposits show
autofluorescence when stained with thioflavin T [2, 5] and bind
the lectin wheat germ agglutinin [3]. Both diseases are strongly
associated with glomerular complement deposition without im-
mune complex deposition [6]. Congenital factor H deficiency is
the undisputable cause of the unrestricted alternative comple-
ment activation and the subsequent nephritis in pigs [7, 8]. The
pathogenesis of human MPGN type II has been elusive, but the
Table 3. Complementologic, biochemical, and hematological parameters; median values (27–75 percentiles)
Unit
2 weeks 4 weeks
FHD Normal Pa FHD Normal
N 30b 68c 28b 47d
Age Days 12 (11–14) 11.5 (11–14) 26.5 (25–28.8) 27 (25–29)
Factor H mg/liter 0.7 (0.6–0.8) 24.9 (21.7–42.4) 0.0000 1.1 (0.8–1.5) 36.6 (31.9–41.2)
C3 % 4.5 (3.6–5.5) 55.6 (39.2–80.2) 0.0000 5.9 (4.3–6.9) 64.7 (45.8–94.0)
TCC AU/ml 19.1 (11.0–21.7) 1.6 (0.9–2.2) 0.0000 15.9 (13.6–20.6) 1.6 (1.0–2.5)
Total protein g/liter 45.5 (42.0–49.0) 51.0 (47.0–56.0) 0.0000 39.5 (36.3–43.8) 51.0 (46.0–58.0)
Albumin g/liter 22.0 (19.1–26.5) 24.0 (21.0–26.0) .0.05 17.3 (15.5–20.5) 28.2 (26.1–31.2)
a-globulin g/liter 9.7 (8.2–12.2) 9.3 (7.8–11.1) .0.05 12.3 (10.0–15.1) 8.5 (7.0–10.2)
b-globulin g/liter 6.6 (4.9–9.1) 8.9 (7.7–10.7) 0.0001 6.7 (5.1–7.0) 9.5 (8.1–10.9)
g-globulin g/liter 4.9 (3.2–6.2) 8.3 (4.8–11.8) 0.0001 2.2 (1.8–2.7) 4.0 (3.3–4.9)
Urea mM 2.6 (1.9–3.2) 2.0 (1.6–2.6) 0.007 20.0 (7.2–45.1) 1.6 (1.3–2.1)
Creatinine mM 79 (67–95) 72 (66–77) 0.02 208 (142–1111) 87 (83–93)
Inorg. phosph. mM 3.0 (2.9–3.3) 3.2 (3.0–3.5) 0.02 3.2 (2.8–4.8) 3.2 (2.8–3.5)
Calcium mM 2.8 (2.7–2.9) 2.9 (2.8–3.0) .0.05 2.4 (1.4–2.6) 2.8 (2.7–3.1)
Cholesterol mM 5.1 (4.6–6.0) 5.0 (4.6–6.3) .0.05 5.2 (4.2–6.3) 4.8 (4.2–5.3)
Triglycerides mM 1.0 (0.8–1.3) 1.3 (0.9–1.7) .0.05 1.6 (1.2–2.0) 1.3 (1.0–1.8)
Hemoglobin g/liter 91 (77–100) 96 (77–105) .0.05 98 (84–101) 105 (100–115)
Hematocrite % 29.5 (25.0–32.3) 31.0 (25.3–35.0) .0.05 29.0 (26.0–32.0) 33.0 (31.0–35.0)
RBC 1012/liter 4.5 (4.0–4.8) 4.5 (3.9–4.9) .0.05 5.4 (5.0–6.2) 6.1 (5.6–6.7)
WBC 109/liter 7.0 (6.4–8.0) 6.2 (5.3–7.5) 0.04 16.7 (10.5–20.7) 9.2 (7.7–13.8)
Neutrophils 109/liter 3.2 (2.7–4.1) 2.5 (1.8–3.2) 0.002 8.4 (6.3–14.9) 3.1 (2.1–4.3)
Lymphocytes 109/liter 2.6 (2.1–3.4) 3.2 (2.5–3.8) 0.01 4.3 (3.5–5.4) 4.7 (3.5–9.1)
Platelets 109/liter 508 (352–966) 682 (522–1035) 0.04 533 (375–700) 589 (469–740)
MPV fl 5.8 (4.7–6.3) 6.1 (5.6–6.5) 0.05 6.1 (5.4–6.3) 6.4 (5.8–6.7)
Abbreviations are: C3, complement component 3; FHD, factor H deficient; MPV, mean platelet volume; RBC, red blood cells; TCC, the terminal
complement complex; WBC, white blood cells.
a Difference between FHD and normal, Mann-Whitney two sample test
b Numbers for factor H (4 weeks, N 5 17; 6 weeks, N 5 8); numbers for C3 and TCC (4 weeks, N 5 20; 6 weeks, N 5 10); numbers for cholesterol
and triglycerides (2 weeks, N 5 7; 4 weeks, N 5 20; 6 weeks, N 5 11)
c numbers for factor H (N 5 59), urea and creatinine (n 5 58), cholesterol and triglycerides (N 5 14)
d numbers for factor H (N 5 19); numbers for C3 and TCC (N 5 27); numbers for cholesterol and triglycerides (N 5 24)
e numbers for factor H (N 5 24); C3 and TCC (N 5 22); urea, creatinine and platelets (N 5 63); cholesterol and triglycerides (N 5 29)
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disease has been strongly associated with persistent hypocomple-
mentemia [4] due to alternative complement pathway activation
caused by C3 nephritic factor (C3NeF), an IgG autoantibody
directed against the alternative C3 convertase, C3bBb. Factor H is
an important regulator at this point, by dissociating the C3bBb
complex and acting as a cofactor for the enzymatic inactivation of
C3b. C3NeF stabilizes the C3bBb complex by preventing the
binding of factor H, thereby inducing a state of factor H dysfunc-
tion with uncontrolled C3 activation and profound hypocomple-
mentemia [24–26]. A few cases of human MPGN type II have
been described in association with factor H deficiency [27] or in
other instances of factor H dysfunction [28, 29]. The indisputable
fact that MPGN type II regularly recurs in renal allografts show
that a serum factor is mandatory in the disease development. This
factor is likely to be C3NeF in most cases of MPGN type II. Most
clinical studies in humans have, however, failed to demonstrate
any correlation between serum C3NeF titers, hypocomple-
mentemia and the clinical course of MPGN type II. Furthermore,
a few humans had serum C3NeF without developing nephritis.
Thus, it has not been ascertained whether the complement
activation is the cause or the consequence of MPGN, and most
authors have considered complement activation in MPGN as an
epiphenomenon [4, 30, 31]. Although human factor H deficiency
is closely associated with MPGN, it is also associated with other
forms of GN [32], the hemolytic uremic syndrome [33, 34], or
meningococcal infections [35, 36]. Studies of the relatives of factor
H deficient patients have revealed that some factor H deficient
humans seem to be healthy. There may be several explanations to
these obvious inconsistencies between the porcine and the human
variants of the disease. The observation of systemic and local
complement activation as two mutually independent events in
porcine factor H deficiency may also apply to factor H dysfunction
caused by C3NeF in humans. It is likely that the local effect of
C3NeF binding to the alternative pathway C3-convertase within
the GBM and the mesangial matrix is important to the initiation
of the nephritis, and the sustained glomerular complement acti-
vation may incite a vicious cycle of glomerular cell damage that
determines the course of the disease. In this context it is note-
worthy that, whereas anti-GBM antibody detection is of great
diagnostic significance in anti-GBM GN, the antibody serum titer
has only limited prognostic value [37]. Still, there are few who
would dispute the importance of anti-GBM antibodies in the
pathognesis of anti-GBM GN. There is also a possibility that
observations by IFM of incipient solitary glomerular C3 deposits
may have been underestimated as MPGN type II, because the
pathogenetic importance of such complement deposits has been
most uncertain and because the demonstration of concurrent
intramembranous dense deposits by TEM is a prerequisite of this
diagnosis [4, 31]. The association between human factor H
deficiency and the hemolytic uremic syndrome may rely on a
species’ inherent sensitivity of human endothelial cells to the
activated components of the complement system [33, 34]. Inter-
estingly, the hemolytic uremic syndrome has also been observed in
human C3NeF-associated hypocomplementemia, and glomerular
capillary wall deposition of C3 was also observed in these cases
[34, 38]. Consequently, in addition to the strong morphologic and
immunohistochemical similarities between the disease in the
porcine and human species, the similarity may also apply to the
etiology that is considered to be factor H dysfunction. At present,
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Fig. 8. Weight development of factor H deficient piglets. The solid weight
curves represent the 9 individual factor H deficient piglets that were
subjected to renal biopsies in this study. One piglet (#) was euthanized
before development of uremia because of peritonitis. The remaining
piglets had severe kidney failure at death. Three piglets were euthanized
(asterisks), whereas the remaining five piglets died spontaneously. The 2.5,
10, 25, 50, 75, 90 and 97.5 percentile normal weight curves shown in the
diagram with broken lines were calculated from 1312 observations in 273
normal Yorkshire piglets (mainly littermates of factor H deficient piglets).
Table 3. Continued
Pa
6 weeks
FHD Normal Pa
14b 73e
42 (39–47) 42 (37–44)
0.0000 1.3 (1.0–1.5) 34.5 (31.0–37.0) 0.0000
0.0000 6.2 (4.8–7.2) 68.9 (44.1–86.1) 0.0000
0.0000 9.3 (5.7–17.9) 1.8 (1.0–2.3) 0.0000
0.0000 33.0 (27.5–42.5) 45.5 (42.0–49.0) 0.0001
0.0000 12.0 (9.2–17.2) 24.1 (22.5–25.9) 0.0000
0.0003 12.2 (9.9–15.6) 9.4 (7.9–10.6) 0.009
0.0000 7.8 (6.0–8.6) 8.1 (6.8–10.0) .0.05
0.0000 3.1 (2.6–5.0) 3.8 (3.1–4.6) .0.05
0.0000 34.2 (16.6–54.9) 2.3 (1.8–2.9) 0.0000
0.0000 249 (230–1324) 98 (93–111) 0.0000
.0.05 3.3 (2.8–5.3) 3.0 (2.8–3.3) .0.05
0.0000 2.0 (1.1–2.2) 2.7 (2.6–2.8) 0.0000
.0.05 4.9 (3.2–7.4) 3.4 (2.3–5.0) .0.05
.0.05 1.4 (0.8–2.4) 0.6 (0.5–0.9) 0.0004
0.0000 93 (69–102) 107 (96–115) 0.003
0.0001 29.0 (21.0–32.0) 35.0 (31.0–36.0) 0.0001
0.0001 5.4 (4.1–6.3) 6.5 (6.1–7.1) 0.0003
0.0000 19.9 (16.5–33.8) 14.0 (11.0–16.9) 0.0003
0.0000 10.6 (8.8–23.9) 3.7 (2.1–5.9) 0.0000
.0.05 6.3 (3.2–7.0) 7.8 (6.2–10.0) 0.004
.0.05 335 (238–541) 551 (442–708) 0.003
0.03 5.6 (5.3–5.9) 6.7 (6.3–6.9) 0.0000
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there is no convincing evidence for any other etiology in this
disease.
The process of mesangial cell proliferation occurs faster in
porcine MPGN type II than in the human disease. However, even
if the genetic deficiency is identical in all factor H deficient pigs,
a certain variation of the glomerulonephritic phenotype was
observed, and there was substantial variation of survival, since
affected pigs died from uremia between the ages of 22 and 269
days [5, 39]. This suggests that some interindividual variation
exists between factor H deficient pigs with respect to the inflam-
matory response to in situ glomerular complement activation.
Similarly, it is obvious that some inter-species differences with
respect to the clinical course of MPGN type II in pigs and humans
are present, since the median renal survival in humans is 8.7 years
[40]. Several factors may contribute to such inter-species varia-
tions. First, pigs grow much faster than humans, reflecting a more
rapid cell proliferation. In the present study the factor H deficient
piglets had a tenfold weight gain from 1.2 kg to 12 kg (Fig. 8)
within seven weeks, and pigs usually reach 100 kg at six months of
age shortly before the onset of sexual maturity. Second, porcine
and human mesangial cells may respond differently to the expo-
sure of released complement activation products. This may reflect
species differences in the expression of certain fluid phase and
membrane bound complement inhibitory proteins. Complement
activation causes up-regulation of the expression of certain com-
plement regulators on human mesangial cells [41, 42]. In addition,
human plasma contains a soluble form of CR1 (sCR1), which may
to some extent substitute for the activities of factor H [43]. A
porcine analog of human CR1 has not been described. However,
human plasma sCR1 is normally present in very low concentra-
tions (;30 ng/ml), which is in the range of 1024 of the normal
factor H plasma concentration. Consequently, even if sCR1 may
increase fivefold in certain disease conditions, its complement
inhibitory effect in factor H dysfunction is probably of limited
significance. Human serum also contains several factor H-related
or factor H-like proteins that shows immunological cross-reactiv-
ity with factor H [44]. The 42 kDa factor H-like protein 1 has
functional activity similar to factor H. It has cofactor activity in
factor I-mediated cleavage of C3b as well as decay-acceleration
activity that dissociates the C3/C5 convertases [45, 46]. Factor
H-like protein 1 may exhibit sufficient activity to prevent clinical
disease in some human beings.
Human MPGN type II is associated with complement deposi-
tion and intramembranous dense deposits in extraglomerular
renal basement membranes and extrarenal manifestations such as
partial lipodystrophy and occurrence of intramembranous dense
deposits in the basement membranes of the eye [4, 47, 48]. The
finding of normal histology with negative IFM for complement in
all the examined extrarenal organs indicates that complement
deposition in factor H deficient piglets probably is unique to the
renal glomeruli. The extraglomerular and extrarenal tissue dense
deposits in human MPGN type II may be explained by the
relatively slow progression of the disease, which may over time
allow complement activation on basement membranes less inti-
mately exposed to circulating blood than the GBM. It may also
reflect anatomical differences between pigs and human beings. In
humans both the GBM and the basement membrane (Bruchs
membrane) of the choroidea of the eye are exposed to circulating
blood through endothelial fenestrations [48]. The absence of
ocular lesions in factor H deficient piglets indicates that the
corresponding structures are less intimately exposed to circulating
blood.
Capillary wall double contours are closely associated with
mesangial interposition and GBM reduplication, especially in
human MPGN type I [4, 49]. Circumferential IFM double con-
tours in human MPGN type II, the so-called “railroad tracks,”
result from C3 deposits along the margins, but not within the
central portions of intramembranous dense deposits [50, 51].
Disintegration of intramembranous dense deposits has not been
associated with the occurrence of “railroad tracks” in the human
disease; however, in a study of human dense deposit disease the
intramembranous dense deposits occasionally exhibited signs of
dissolution [52]. A previous study of allograft recurrence of
intramembranous dense deposits in human MPGN type II, sug-
gested that the dense deposits appeared prior to complement
deposits and constituted the primary marker of the disease [53].
For comparison, renal allotransplantation from a normal pig to a
factor H deficient pig showed renal allograft recurrence of
glomerular complement deposits within 24 hours without the
occurrence of intramembranous dense deposits [22]. These latter
referred discrepancies between the porcine and human variants of
the disease may reflect some difference with respect to the
pathogenesis of the two diseases. However, the many striking
similarities between the disease in pigs and humans stated above
indicate a pathogenetic role of factor H dysfunction also in the
development of human MPGN type II, and future research may
resolve these elusive immunopathologic discrepancies.
We have shown that porcine factor H deficiency consistently
causes in situ glomerular complement activation within the GBM.
This already occurs in utero prior to the appearance of intramem-
branous dense deposits or mesangial proliferation. When the
intramembranous dense deposits appear, they contain comple-
ment. Kidney failure coincides with the secondary morphologic
phenomenon of pronounced mesangial cell proliferation that
cause loss of glomerular capillary patency. Because of the many
striking similarities with human MPGN type II, we propose that
factor H dysfunction may be a main cause of the corresponding
human disease.
Table 4. Complement parameters; median values (25–75 percentiles)
Unit
Fetuses, 35 days preterm
Pa
Neonates
Pa
1 week
PaFHD (N 5 10) Normal (N 5 9) FHD (N 5 28) Normal (N 5 62) FHD (N 5 27) Normal (N 5 85)
FH mg/liter 0.2 (0.2–0.3) 8.9 (5.8–16.9) 0.0003 3.2 (2.4–4.0) 35 (24–53) 0.0000 1.6 (1.4–1.8) 54 (40–77) 0.0000
C3 % 0.4 (0.3–0.5) 4.9 (4.4–9.4) 0.0003 1.3 (1.0–2.1) 6.6 (4.1–9.2) 0.0000 4.6 (3.5–6.3) 46 (34–60) 0.0000
TCC AU/ml 0.4 (0.3–0.5) 0.1 (0.05–0.3) 0.0014 3.1 (2.1–5.5) 1.2 (0.5–2.2) 0.0000 16 (13–21) 1.4 (0.8–2.0) 0.0000
Abbreviations are: C3, complement component 3; FH, factor H; FHD, factor H deficient; TCC, the terminal complement complex.
a Difference between FHD and normal, Mann-Whitney two sample test
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APPENDIX
Abbreviations used in this article are: MPGN, membranoproliferative
glomerulonephritis; GBM, glomerular basement membrane; MCGN,
mesangiocapillary glomerulonephritis; C3NeF, C3 nephritic factor; LM,
light microscopy; TEM, transmission electron microscopy; IFM, immuno-
fluorescence microscopy; IEM, immune electron microscopy; HE, hema-
toxylin-eosin stain; PAS, periodic acid Schiff stain; FITC, fluorescein
isothiocyanate; TRITC, tetramethyl rhodamine isothiocyanate; HPLC,
high pressure liquid chromatography; IF, immunofluorescence; DAF,
decay accelerating factor; MCP, membrane cofactor protein; CR1, com-
plement receptor 1; C3bBb, alternative C3 convertase; sCR1, soluble form
of CR1.
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